Evaluation of the need for cytoreduction and its potential carcinogenicity in children and young adults with myeloproliferative neoplasms-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluation of the need for cytoreduction and its potential carcinogenicity in children and young adults with myeloproliferative neoplasms

Published:2021-07-30 Issue:10 Volume:100 Page:2567-2574
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Choi Hyoung Soo,Hong Junshik,Hwang Sang Mee,Lee Ju Hyun,Ma Youngeun,Kim Sang-A,Lee Ji Yun,Lee Jeong-Ok,Bang Soo-Mee

Funder

Seoul National University Bundang Hospital

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00277-021-04527-7.pdf

Reference39 articles.

1. Tefferi A, Pardanani A (2015) Myeloproliferative neoplasms: a contemporary review. JAMA Oncol 1:97–105. https://doi.org/10.1001/jamaoncol.2015.89

2. Barbui T, Thiele J, Gisslinger H et al (2018) The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion. Blood Cancer J 8:1–11. https://doi.org/10.1038/s41408-018-0054-y

3. Tefferi A, Barbui T (2019) Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management. Am J Hematol 94:133–143. https://doi.org/10.1002/ajh.25303

4. Landtblom AR, Bower H, Andersson TML et al (2018) Second malignancies in patients with myeloproliferative neoplasms: a population-based cohort study of 9379 patients. Leukemia 32:2203–2210. https://doi.org/10.1038/s41375-018-0027-y

5. Hong J, Lee JH, Byun JM et al (2019) Risk of disease transformation and second primary solid tumors in patients with myeloproliferative neoplasms. Blood Adv 3:3700–3708. https://doi.org/10.1182/bloodadvances.2019000655

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polycythemia vera and essential thrombocythemia of intermediate-age: A real-life, multicenter analysis of first-line treatment approach;Advances in Clinical and Experimental Medicine;2024-04-29

2. Essential Thrombocythemia in Adolescents and Young Adults: Clinical Aspects, Treatment Options and Unmet Medical Needs;Current Treatment Options in Oncology;2023-05-17

3. A Case Report of Ropeginterferon Alfa-2b for Polycythemia Vera during Pregnancy;Hematology Reports;2023-03-02

4. Essential Thrombocythemia and Post-Essential Thrombocythemia Myelofibrosis: Updates on Diagnosis, Clinical Aspects, and Management;Laboratory Medicine;2022-08-12

5. Validation of thrombotic risk factors in 1381 patients with essential thrombocythaemia: A multicentre retrospective real‐life study;British Journal of Haematology;2022-07-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3